Effects of α-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid

Neuroscience

Volumn 76, Issue 3, 1996, Pages 749-761

  Nakao, N ^a,b   Brundin, P ^a  

^a LUND UNIVERSITY   (Sweden)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

behavioural test; DARPP 32; excitotoxic injury; free radicals; Huntington's disease; multiple system atrophy

Indexed keywords

3 NITROPROPIONIC ACID; AMPHETAMINE; APOMORPHINE; EXCITOTOXIN; FREE RADICAL; N TERT BUTYL ALPHA PHENYLNITRONE; NEUROPROTECTIVE AGENT; PHOSPHOPROTEIN DARPP 32; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; HUNTINGTON CHOREA; IMMUNOCYTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030580581     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(96)00223-0     Document Type: Article

References (61)

1. 1. Albin R. L., Reiner A., Anderson K. D., Penny J. B. and Young A. B. (1990) Striatal and nigral neuron subpopulation in rigid Huntington's disease: implication for the functional anatomy of chorea and rigidity-akinesia. Ann. Neurol. 27, 357-365.
2. 2. Alston T. A., Meda L. and Bright H. J. (1977) 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc. natn. Acad. Sci. U.S.A. 74, 3767-3771.
3. 3. Banati R. B., Gehrmann J., Schubert P. and Kreutzberg G. W. (1993) Cytotoxicity of microglia. Glia 7, 111-118.
4. 4. Beal M. F., Swartz K. J., Hyman B. T., Storey E., Finn S. F. and Koroshetz W. (1991) Aminooxyacetic acid results in excitotoxic lesions by a novel indirect mechanism. J. Neurochem. 57, 1068-1073.
5. 5. Beal M. F., Brouillet E., Jenkins B. G., Ferrante R. J., Kowall N. W., Miller J. M., Storey E., Srivastava R., Rosen B. R. and Hyman B. T. (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13, 4181-4192.
6. 6. Beal M. F., Hyman B. T. and Koroshetz W. (1993) Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?. Trends Neurosci. 16, 125-131.
7. 7. Björklund A., Campbell K., Sirinathsinghji D. J. S. and Fricker R. A. and Dunnett S. B. (1994) Functional capacity of striatal transplants in the rat Huntington model. In Functional Neural Transplantation (eds Dunnett S. B. and Björklund A.), pp. 157-195. Raven Press, New York.
8. 8. Bondy S. C. and Lee D. K. (1993) Oxidative stress induced by glutamate receptor agonists. Brain Res. 610, 229-233.
9. 9. Brouillet E., Jenkins B. G., Hyman B. T., Ferrante R. J., Kowall N. W., Srivastava R., Roy D. S., Rosen B. R. and Beal M. F. (1993) Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 60, 356-359.
10. 10. Bruyn G. W. (1968) Huntington's chorea: historical, clinical and laboratory synopsis. In Handbook of Clinical Neurology, Vol 6, Disease of Basal Ganglia (eds Vinken P. J. and Bruyn G. W.), pp. 298-377. Elsevier, Amsterdam.
11. 11. Carman L. S., Gage F. H. and Shults C. W. (1991) Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res. 553, 275-283.
12. 12. Coyle J. T. and Puttfarcken P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
13. 13. DiFiglia M. (1990) Excitotoxic injury of the neostriatum: a model for Huntington's disease. Trends Neurosci. 13, 286-289.
14. 14. Dunnett S. B., Isacson O., Sirinathsinghji D. J. S., Clarke D. J. and Björklund A. (1988) Striatal grafts in rats with unilateral neostriatal lesions - III. Recovery from dopamine-dependent motor asymmetry and deficits in skilled paw reaching. Neuroscience 24, 813-820.
15. 15. Dykens J. A., Stern A. and Trenkner E. (1987) Mechanism of kainate toxicity to cerebellar neurons in vitro is analogous to reperfusion tissue injury. J. Neurochem. 49, 1222-1228.
16. 16. Eriksson N. P., Persson J. K. E., Svensson M., Arvidsson J., Molander C. and Aldskogius H. (1993) A quantitative analysis of the microglial cell reaction in central primary sensory projection territories following peripheral nerve injury in the adult rat. Expl Brain Res. 96, 19-27.
17. 17. Fearnley J. M. and Lees A. J. (1990) Striatonigral degeneration. A clinicopathological study. Brain 113, 1823-1842.
18. 18. Fricker R. A., Annett L. E. and Torres E. M. and Dunnett S. B. (1996) The placement of a striatal ibotenic acid lesion affects skilled forelimb use and the direction of drug-induced rotation (submitted).
19. 19. Gerfen C. R., Herkenham M. and Thibault J. (1987) The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J. Neurosci. 7, 3915-3934.
20. 20. Greene J. G., Porter R. H. P., Eller R. V. and Greenamyre J. T. (1993) Inhibition of succinate dehydrogenase by malonic acid produces an "excitotoxic" lesion in rat striatum. J. Neurochem. 43, 1369-1374.
21. 21. Harper P. S. (1991) Huntington's disease. In Major Problems in Neurology, Vol. 22. Saunders, London.
22. 22. Hefti F., Melamed E. and Wurtman R. J. (1980) Partial lesions of the dopaminergic nigrostriatal system in rat brain: biochemical characterization. Brain Res. 195, 123-137.
23. 23. Isacson O., Brundin P., Kelly P. A. T., Gage F. H. and Björklund A. (1984) Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum. Nature 311, 458-460.
24. 24. Isacson O., Dunnett S. B. and Björklund A. (1986) Graft-induced behavioral recovery in an animal model of Huntington's disease. Proc. natn. Acad. Sci. U.S.A. 83, 2728-2732.
25. 1H NMR spectroscopy. Neurology 43, 2689-2695.
26. 26. Koutouzis T. K., Borlongan C. V., Freeman T. B., Cahill D. W. and Sanberg P. R. (1994) Intrastriatal 3-nitropropionic acid: a behavioral assessment. NeuroReport 5, 2241-2245.
27. 27. Koutouzis T. K., Borlongan C. V., Scorcia T., Creese I., Cahill D. W., Freeman T. B. and Sanberg P. R. (1994) Systemic 3-nitropropionic acid: long-term effects on locomotor behavior. Brain Res. 646, 242-246.
28. 28. Krammer E. G. (1980) Anterograde and transsynaptic degeneration "en cascade" in basal ganglia induced by intrastriatal injection of kainic acid: an animal analogue of Huntington's disease. Brain Res. 196, 209-221.
29. 29. Li X.-J., Li S.-H., Sharp A. H., Nucifora F. C. Jr, Schiiling G., Lanahan A., Worley P., Snyder S. H. and Ross C. A. (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378, 398-402.
30. 30. Ludolph A. C., He F., Spencer P. S., Hammerstadt J. and Sabri M. (1991) 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can. J. neurol. Sci. 18, 492-498.
31. 31. Lundberg C., Wictorin K. and Björklund A. (1994) Retrograde degenerative changes in the substantia nigra pars compacta following an excitotoxic lesion of the striatum. Brain Res. 644, 205-212.
32. 32. Montoya C. P., Campbell H. L., Pemberton K. D. and Dunnett S. B. (1991) The "staircase test": a measure of independent forelimb reaching and grasping abilities in rats. J. Neurosci. Meth. 36, 219-228.
33. 33. Monyer M., Goldberg M. F. and Choi D. W. (1989) Glucose deprivation neuronal injury in cortical cell culture. Brain Res. 483, 347-354.
34. 34. Nakao N., Grasbon-Frodl E. M., Widner H. and Brundin P. (1996) Antioxidant treatment protects striatal neurons against excitotoxic insults. Neuroscience 73, 185-200.
35. 35. Novelli A., Reilly J. A., Lysko P. G. and Henneberry R. C. (1988) Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced. Brain Res. 451, 205-212.
36. 36. Oliver C. N., Starke-Reed P. E., Stadtman E. R., Liu G. J., Carney J. M. and Floyd R. A. (1990) Oxidative damage to brain proteins, loss of glutamate synthetase activity, and production of free radicals during ischemia/reperfusion-induced injury to gerbil brain. Proc. natn. Acad. Sci. U.S.A. 87, 5144-5147.
37. 37. Ouimet C. C. and Greengard P. (1990) Distribution of DARPP-32 in the basal ganglia: an electron microscopic study. J. Neurocytol. 19, 39-52.
38. 38. Ouimet C. C., Miller P. E., Hemmings H. C. Jr, Walaas S. I. and Greengard P. (1984) DARPP-32, a dopamine- and adenosine 3′:5′-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. III. Immunocytochemical localization. J. Neurosci. 4, 111-124.
39. 39. Oyanagi K., Takeda S., Takahashi H., Ohama E. and Ikuta F. (1989) A quantitative investigation of the substantia nigra in Huntington's disease. Ann. Neurol. 26, 13-19.
40. 40. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA.
41. 41. Persson J. K. E., Aldskogius H., Arvidsson J. and Holmberg A. (1991) Ultrastructural changes in the gracile nucleus of the rat after sciatic nerve transection. Anat. Embryol. 184, 591-604.
42. 42. Pisa M. (1988) Motor function of the striatum in the rat: critical role of the lateral region in tongue and forelimb reaching. Neuroscience 24, 453-463.
43. 43. Puttfarcken P. S., Getz R. L. and Coyle J. T. (1993) Kainic acid-induced lipid peroxidation: protection with butylated hydroxytoluene and U78517F in primary cultures of cerebellar granule cells. Brain Res. 624, 223-232.
44. 44. Saji M. and Reis D. J. (1987) Delayed transneuronal death of substantia nigra neurons prevented by γ-aminobutyric acid agonist. Science 235, 66-68.
45. 45. Sanberg P. R., Henault M. A. and Deckel A. W. (1986) Locomotor hyperactivity: effects of multiple striatal transplants in an animal model of Huntington's disease. Pharmac. Biochem. Behav. 25, 297-300.
46. 46. Sastray S. and Arendash G. W. (1995) Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex. Neuroscience 67, 649-666.
47. 47. Schulz J. B., Henshaw D. R., Siwek D., Jenkins B. G., Ferrante R. J., Cipolloni P. B., Kowall N. W., Rosen B. R. and Beal M. F. (1995) Involvement of free radicals in excitotoxicity in vivo. J. Neurochem. 64, 2239-2247.
48. 48. Schwarcz R., Fuxe K., Agnati L. F., Hökfelt T. and Coyle J. T. (1979) Rotational behaviour in rats with unilateral striatal kainic acid lesions: a behavioural model for studies on intact dopamine receptors. Brain Res. 170, 485-495.
49. 49. Thanos S., Mey J. and Wild M. (1993) Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degeneration and enhances axonal regeneration in vivo and in vitro. J. Neurosci. 13, 455-466.
50. 50. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
51. 51. Töpper R., Gehrmann J., Schwarz M., Block F., Noth J. and Kreutzberg G. W. (1993) Remote microglial activation in the quinolinic acid model of Huntington's disease. Expl Neurol. 123, 271-283.
52. 52. Ungerstedt U. and Arbuthnott G. W. (1970) Quantitative recording of rotational behaviour in rats after 6-hydroxydopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 485-493.
53. 53. Veening J. G., Cornelissen F. M. and Lieven P. A. J. M. (1980) The topical organization of the afferents to the caudatoputamen of the rat. A horseradish peroxidase study. Neuroscience 5, 1253-1268.
54. 54. Weller M. and Paul S. M. (1993) 3-Nitropropionic acid is an indirect excitotoxin to cultured cerebellar granule neurons. Eur. J. Pharmac. 248, 223-228.
55. 55. Whishaw I. Q., O'Connor W. T. and Dunnett S. B. (1985) The contributions of motor cortex, nigrostriatal dopamine and caudate-putamen to skilled forelimb use in the rat. Brain 109, 805-843.
56. 56. Wieloch T. (1985) Hypoglycemia-induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science 230, 681-683.
57. 57. Wüllner U., Young A. B., Penny J. B. and Beal M. F. (1994) 3-Nitropropionic acid toxicity in the striatum. J. Neurochem. 63, 1772-1781.
58. 58. Yue T.-L., Gu J.-L., Lysko P. G., Cheng H.-Y., Barone F. C. and Feuerstein G. (1992) Neuroprotective effects of phenyl-t-butyl-nitrone in gerbil global brain ischemia and in cultured rat cerebellar neurons. Brain Res. 574, 193-197.
59. 59. Zeevalk G. D. and Nicklas W. J. (1990) Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina. J. Pharmac. exp. Ther. 253, 1285-1292.
60. 60. Zeevalk G. D. and Nicklas W. J. (1991) Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. J. Pharmac. exp. Ther. 257, 870-878.
61. 61. Zeevalk G. D., Derr-Yellin E. and Nicklas W. J. (1995) NMDA receptor involvement in toxicity to dopamine neurons in vitro caused by the succinate dehydrogenase inhibitor 3-nitropropionic acid. J. Neurochem. 64, 455-458.